Clinical Trial Update: A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reports on the efficacy and safety of LB54640 in adults with hypothalamic obesity; the study has completed enrollment/status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothalamic Obesity

Drugs mentioned

• LB54640

Snippet

Sponsor: Rhythm Pharmaceuticals, Inc. | Conditions: Hypothalamic Obesity | Phase 2 | Status: COMPLETED